OPTIMIZERX CORP
OPRXNASDAQTrading Snapshot
- Day Range
- $6.49 – $6.66
- 52-Week Range
- $4.54 – $22.25
- Volume
- $2.93B
- Avg Volume
- $3.03B
- Shares Outstanding
- 18.8M
- Next Earnings
- Oct 5, 2026
Fundamentals Snapshot
- Annual Revenue
- $109M
- Last Q Revenue
- $20M
- P/E Ratio
- 17.9
- P/S Ratio
- 1.1x
- EPS (TTM)
- $0.36
- Dividend Yield
- 0.00%
Why Investors Own OPRX
- ✓High-growth profile — revenue up +50.6% YoY with expanding US Equity exposure.
- ✓Healthy economics — 43% gross margin and 13% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About OPTIMIZERX CORP
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
PTC Inc. (PTC) Q3 Earnings and Revenues Miss Estimates
PTC Inc. (PTC) delivered earnings and revenue surprises of -1.25% and -2.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
WALTHAM, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at the most important decision points, will hold a conference call on Wednesday, August 12, 2026, at 4:30 p.m. Eastern Time to discuss its results for the second quarter period ended June 30, 2026. The financial results will be issued in a press release
Commvault Systems (CVLT) Beats Q1 Earnings and Revenue Estimates
Commvault (CVLT) delivered earnings and revenue surprises of +20.34% and +0.99%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
Leading pharmaceutical marketing executive joins leadership team to accelerate innovation and strengthen partnerships across the life sciences industryWALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, today announced the appointment of Sarah Bast as Chief Marketing Officer. Bas
Pegasystems (PEGA) Lags Q2 Earnings and Revenue Estimates
Pegasystems (PEGA) delivered earnings and revenue surprises of -18.61% and -1.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?